(Q45279430)

11 December 2017

title

The human liver clears both asymmetric and symmetric dimethylarginine (English)

1 reference

11 December 2017

Michiel P C Siroen

1

1 reference

11 December 2017

Joost R M van der Sijp

2

1 reference

11 December 2017

Tom Teerlink

3

1 reference

11 December 2017

Cors van Schaik

4

1 reference

11 December 2017

Robert J Nijveldt

5

1 reference

11 December 2017

Paul A M van Leeuwen

6

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

11 December 2017

1 reference

11 December 2017

volume

41

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

559-565

1 reference

Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

11 December 2017

cites work

1 reference

Studies on the catabolism of NG-methylarginine, NG, NG-dimethylarginine and NG, NG-dimethylarginine in the rabbit

21 January 2018

1 reference

Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L‐arginine in regenerated endothelial cells

21 January 2018

1 reference

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

7 January 2021

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

1 reference

7 January 2021

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans

1 reference

7 January 2021

Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia

1 reference

7 January 2021

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

7 January 2021

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients

1 reference

7 January 2021

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody

1 reference

7 January 2021

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody

1 reference

7 January 2021

Urinary excretion of methylarginine in human disease

1 reference

7 January 2021

The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).

1 reference

7 January 2021

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

1 reference

7 January 2021

The transplanted liver graft is capable of clearing asymmetric dimethylarginine

1 reference

7 January 2021

Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis

1 reference

7 January 2021

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

1 reference

7 January 2021

Total and functional hepatic blood flow decrease in parallel with ageing

1 reference

7 January 2021

Metabolism of NG,NG-and NG,N'G-dimethylarginine in rats

1 reference

7 January 2021

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases

1 reference

7 January 2021

Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency

1 reference

7 January 2021

Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia

1 reference

7 January 2021

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

1 reference

7 January 2021

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

1 reference

7 January 2021

Endogenous nitric oxide synthase inhibitors are responsible for the L -arginine paradox

1 reference

7 January 2021

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

1 reference

7 January 2021

The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20579

1 reference

11 December 2017

1 reference